Lipid Profile, Waist Circumference, and Body Mass Index in a High Altitude Population

2006 ◽  
Vol 7 (3) ◽  
pp. 245-255 ◽  
Author(s):  
Salim Mohanna ◽  
Rossana Baracco ◽  
Segundo Seclén
2021 ◽  
Vol 26 ◽  
pp. 2515690X2110110
Author(s):  
Wiraphol Phimarn ◽  
Bunleu Sungthong ◽  
Hiroyuki Itabe

Aim. The efficacy of triphala on lipid profile, blood glucose and anthropometric parameters and its safety were assessed. Methods. Databases such as PubMed, ScienceDirect, Web of Science, and Thai Library Integrated System (ThaiLIS) were systematically searched to review current evidence of randomized controlled trials (RCT) on triphala. RCTs investigating the safety and efficacy of triphala on lipid profile, blood glucose and anthropometric parameters were included. Study selection, data extraction, and quality assessment were performed independently by 2 authors. Results. Twelve studies on a total of 749 patients were included. The triphala-treated groups showed significantly reduced low-density lipoprotein-cholesterol, total cholesterol and triglyceride in 6 studies. Five RCTs demonstrated triphala-treated groups led to statistically significant decrease in body weight, body mass index and waist circumference of obese patients. Moreover, triphala significantly decreased fasting blood glucose level in diabetic patients but not in people without diabetes. No serious adverse event associated with triphala was reported during treatment. Conclusions. This review summarized a current evidence to show triphala might improve the lipid profile, blood glucose, the body weight, body mass index and waist circumference under certain conditions. However, large well-designed RCTs are required to confirm this conclusion.


Author(s):  
Utami Ariyasra ◽  
Mohamad Reza ◽  
Dessy Arisanty ◽  
Nur Indrawaty Lipoeto

Background: A hormonal contraception which considered ideal is depot medroxy progesteron acetat. There are large number of acceptors choose this contraception because this contraception is considered safe, effective, and can be used after labor. The possible side effect which can occur are increase of lipid profile, body fat percentage, and waist circumference. The purpose of this study is to see the differences between lipid profile, body fat percentage, and the waist circumference of women of childbearing age who use depot medroxy progesteron acetat injection compared with non-acceptors.Methods: This study was observational study with a cross sectional comparative approach and was conducted at the Regional Technical Services Unit (UPTD) at Regional Health Laboratory in West Sumatera Province from December 2017 until June 2018. The samples were 46 DMPA acceptors and 46 non-acceptors. The sampling method used random sampling technique. The measurements of lipid profile was conducted with colorimetric enzymatic method, which is GPO-PAP for triglycerides, and CHOD-PAP for total cholesterol, HDL and LDL. The percentage of body fat examination was conducted using Bioelectrical Impedance Analysis (BIA). The obtained data were analyzed by using t-test. Abnormal data were confirmed by Mann-whitney non-parametric test with p<0.05.Results: The results showed a significant difference between DMPA acceptors and non-acceptors (p<0.05). In total cholesterol (p = 0.000), LDL (p = 0.000), triglycerides (p = 0.000), body fat percentage (p = 0.007), body mass index (p = 0.004), and waist circumference (p = 0.001). But, in HDL there was no significant difference between DMPA acceptors and non-acceptors with p value = 0.302 (p>0.05). There were significant differences in total cholesterol, LDL, triglycerides, fat percentage, body mass index, and the circumference of waist in both DMPA acceptors and non acceptors. There were no significant difference in HDL levels between DMPA acceptors and non acceptors.Conclusions: There were significant differences in total cholesterol, LDL, triglycerides, fat percentage, body mass index, and waist circumference between DMPA acceptors and non-acceptors. There was no significant difference in HDL between DMPA acceptors and non-acceptors.


2019 ◽  
pp. 931-938
Author(s):  
Ľ. Cibičková ◽  
K. Langová ◽  
H. Vaverková ◽  
J. Lukeš ◽  
N. Cibiček

Coronary risk evaluation by conventional factors (age, gender, smoking, blood pressure and cholesterol) may further be specified by facets of the metabolic syndrome, namely insulin resistance, hypertriglyceridemia and obesity. Although obesity is usually defined as elevated body mass index (BMI), recent data indicate a superior role of waist circumference or hypertri-glyceridemic waist (HTGW) over BMI in the assessment of cardiometabolic risk. In dyslipidemic patients, the specific contributions of risky waist, HTGW or BMI have not been evaluated as yet. 686 dyslipidemic subjects (322 males and 364 females) were enrolled into a cross-sectional study. In each subject basic antropometry (i.e. waist circumference, HTGW, BMI) and laboratory parameters of lipid profile and insulin resistance were determined. Cardiometabolic risk was given by fulfilling the criteria (harmonized definition) of metabolic syndrome. The significance of risky waist, HTGW and BMI were assessed by comparing the respective predictive values for the presence of metabolic syndrome. Dyslipidemic patients with risky waist, HTGW or high BMI have a more atherogenic lipid profile and higher insulin resistance compared to those without risky waist, HTGW or high BMI. Risky waist is stronger predictor of metabolic syndrome (PPV 66 %, NPV 90 %) and thus posesa greater cardiometabolic risk than higher BMI per se does (PPV 42 %, NPV 97 %). The contribution of triglycerides (i.e. HTGW) to these predictive values is marginal (PPV 66 %, NPV 92 %). The present results highlight the superior role of waist circumference as a screening tool over BMI for the evaluation of cardiometabolic risk in dyslipidemic subjects. HTGW brings little additional benefit in risk stratification. Lower BMI proved to be optimal for identifying the subjects with inferior risk.


Author(s):  
Sundus Fadhil Hantoosh ◽  
Haider K Al-rubai ◽  
Dheaa Sh Zageer ◽  
Ibtisam Hammood Naser Al-musawi

ABSTRACTObjective: This study was conducted to investigate the association between age, body mass index (BMI), waist circumference (WC), and incidence ofsymptomatic bacterial urinary tract infections in adult women and to study the impact of infection on lipid profile.Methods: A total of 30 women enrolled with symptomatic bacterial urinary tract infections and 10 healthy women as control group. Mid-stream urinesamples were submitted. BMI, WC, and lipid profile were measured. Both leukocyte esterase and nitrite tests were used to diagnose the urinary tractinfection, and viable quantification was done as confirmatory for the diagnosis.Results: Revealed that there was a significant relationship between the incidence of symptomatic bacterial urinary tract infections and age groups(p=0.04) as age group (21-30) years recorded the highest percentage (33.33%) followed by the age group (31-40) which recorded 30%. No significantassociation was found between BMI, WC and incidence of symptomatic bacterial urinary tract infections (p=0.08, p=0.14) respectively. Comparedto healthy control group, there was a significant decrease in the levels of total cholesterol, triglycerides, high-density-lipoprotein, very-low-densitylipoprotein,and low-density-lipoprotein (p=0.0001, p=0.006, p=0.001, p=0.006, and p=0.0001), respectively.Conclusion: The young women were significantly susceptible to symptomatic bacterial urinary tract infections than other age groups. Both BMI andWC were not significant indicators for the incidence of symptomatic bacterial urinary tract infections in adult women. Adult women with symptomaticbacterial urinary tract infections showed a significant decrease in lipid profile parameters when compared with the control healthy adult women.Keywords: Age, Body mass index, Waist circumference, Lipid profile, Urinary tract infections.


Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 449-P
Author(s):  
TAKESHI KOMATSU ◽  
KAZUYA FUJIHARA ◽  
MAYUKO H. YAMADA ◽  
TAKAAKI SATO ◽  
MASARU KITAZAWA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document